Developing new treatments for small cell lung cancer
Novel therapeutic development for small cell lung cancer
This study is looking at small cell lung cancer to find better treatments using advanced techniques, and it's for patients who are facing this tough type of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10884225 on NIH RePORTER |
What this research studies
This research focuses on small cell lung cancer (SCLC), a type of cancer known for its rapid growth and poor prognosis. The team at Sloan-Kettering is utilizing advanced techniques, including CRISPR technology, to explore the genetic and cellular characteristics of SCLC. They are conducting clinical trials to test new therapies and are analyzing patient samples to better understand how these treatments work. By integrating laboratory discoveries with clinical applications, the research aims to improve outcomes for patients with this challenging cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with small cell lung cancer who are seeking new treatment options.
Not a fit: Patients with other types of lung cancer or those who do not have a diagnosis of small cell lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for small cell lung cancer, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in using CRISPR technology for cancer treatment, indicating that this approach could lead to significant advancements in therapy for small cell lung cancer.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Rudin, Charles M. — Sloan-Kettering Inst Can Research
- Study coordinator: Rudin, Charles M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.